These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6616329)

  • 1. Postreceptorial refractoriness of prolactin release mechanisms.
    Collu R; Ducharme JR; Eljarmak D; Marchisio AM; Bertrand J; Sabbagh I; Guillaumot P; Cohen H
    Can J Physiol Pharmacol; 1983 Jul; 61(7):676-84. PubMed ID: 6616329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA; Masotto C; Ongini E; Racagni G
    Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sulpiride and apomorphine on prolactin release in adrenalectomized animals. Role of sodium ions.
    Collu R; Bouvier C
    Brain Res; 1987 Jan; 401(1):23-9. PubMed ID: 2949800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of postnatal gonads in the maturation of dopaminergic regulation of prolactin secretion in female rats.
    Watanobe H; Takebe K
    Endocrinology; 1987 Jun; 120(6):2212-9. PubMed ID: 3569131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone inhibits sulpiride-induced hyperprolactinaemia in man.
    Bernini GP; Pedrinelli R; Salvetti A; Franchi F; Luisi M
    Eur J Clin Invest; 1985 Oct; 15(5):272-5. PubMed ID: 3935458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent increase in plasma prolactin after pituitary stalk section: role of posterior pituitary dopamine.
    Murai I; Garris PA; Ben-Jonathan N
    Endocrinology; 1989 May; 124(5):2343-9. PubMed ID: 2495929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of postnatal gonads in the maturation of dopaminergic regulation of prolactin secretion in male rats.
    Watanobe H; Takebe K
    Endocrinology; 1987 Jun; 120(6):2205-11. PubMed ID: 3569130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by lithium of dopamine receptors in rat prolactin release.
    Tanimoto K; Maeda K; Chihara K
    Brain Res; 1981 Nov; 223(2):335-42. PubMed ID: 6269703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of dopaminergic antagonism by sulpiride on TRH and VIP-induced prolactin release in nonsuckled lactating rats.
    Haisenleder DJ; Moy JA; Lawson DM
    Life Sci; 1990; 46(25):1867-72. PubMed ID: 2163481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin secretion from human prolactinomas perifused in vitro: effect of TRH, prostaglandin E1, theophylline, dopamine and dopamine receptor blockers.
    Chihara K; Iwasaki J; Minamitani N; Kaji H; Kodama H; Fujita T; Shirataki K; Tamaki N; Matsumoto S
    Acta Endocrinol (Copenh); 1984 Jan; 105(1):6-13. PubMed ID: 6421041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible mechanism of prolactin unresponsiveness to repeated sulpiride administration in man.
    Bernini GP; Gasperi M; Vivaldi MS; Santoni R; Luisi M; Franchi F
    Eur J Clin Pharmacol; 1984; 27(3):375-7. PubMed ID: 6439566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased dopaminergic inhibition of prolactin in the hypoprolactinaemic IPL nude rat.
    Cohen H; Sabbagh I; Guillaumot P; Bertrand J
    J Endocrinol; 1985 Dec; 107(3):325-9. PubMed ID: 4067488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unresponsiveness of prolactin to repeated injection of sulpiride in man.
    Cohen H; Pugeat M; Tourniaire J; Bertrand J
    Eur J Clin Pharmacol; 1983; 25(2):275-7. PubMed ID: 6628512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for the stimulatory effects of opioidergic and serotonergic input signals on prolactin in pregnant rats.
    Sagrillo CA; Voogt JL
    Life Sci; 1992; 50(20):1479-89. PubMed ID: 1579043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of dopamine agonists and haloperidol on release of prolactin, thyroid stimulating hormone, growth hormone and luteinizing hormone in rats.
    Mueller GP; Simpkins J; Meites J; Moore KE
    Neuroendocrinology; 1976; 20(2):121-35. PubMed ID: 958594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of increased prolactin secretion by sulpiride.
    MacLeod RM; Robyn C
    J Endocrinol; 1977 Mar; 72(3):273-7. PubMed ID: 853259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic stimulation of prolactin release.
    Denef C; Manet D; Dewals R
    Nature; 1980 May; 285(5762):243-6. PubMed ID: 6154895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of passive immunization with antisera to vasoactive intestinal polypeptide and peptide histidine isoleucine amide on 5-hydroxy-L-tryptophan-induced prolactin release in rats.
    Kaji H; Chihara K; Abe H; Kita T; Kashio Y; Okimura Y; Fujita T
    Endocrinology; 1985 Nov; 117(5):1914-9. PubMed ID: 3876209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for dopamine-related and TRH-related pituitary TSH and PRL pools in patients with prolactinoma.
    Hanew K; Utsumi A; Sugawara A; Shimizu Y; Yoshinaga K
    Acta Endocrinol (Copenh); 1991 May; 124(5):545-52. PubMed ID: 1903012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of stress-induced secretion of prolactin during development: effects of adrenalectomy, TRH and sulpiride.
    el Feki A; Sakly M
    J Physiol (Paris); 1988; 83(1):36-42. PubMed ID: 3141611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.